Cite
MLA Citation
Samuel Lederman et al.. “Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study.” Lancet, vol. 401, no. 10382, 2023, pp. 1091–1102. http://access.bl.uk/ark:/81055/vdc_100183021860.0x000050